Form 10-K Foresight Acquisition For: Dec 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Getty Images
It seems like everybody who s anybody is hatching a SPAC these days, and for good reason. They could get very rich very fast.
Veteran CEOs, renowned dealmakers and even celebrities have convinced public investors to give them hundreds of millions of dollars to buy businesses through special-purpose acquisition companies.
Among the Chicago business luminaries announcing or completing SPAC deals in the past several weeks are former Walgreens CEO Greg Wasson, tech CEO and investor Sam Yagan and marijuana mogul Joe Caltabiano. They join billionaire real estate investor Sam Zell, Chicago Cubs Chairman Tom Ricketts and former Boeing CEO Dennis Muilenburg.
Truvian raises $105M, plans to submit benchtop blood-testing tech to FDA
Benchtop blood testing startup Truvian raised $105 million in series C funding, which it plans to use to pave the way to submit its device for FDA clearance.
Shares0
Truvian Sciences plans to seek FDA clearance and CLIA certification for its benchtop blood testing device. Photo credit: Truvian Sciences
Truvian Sciences, a startup building a benchtop blood analyzer, raised $105 million in funding.
The San Diego-based company plans to use the funds to seek 510(k) clearance and a CLIA waiver from the Food and Drug Administration, with plans to make its first regulatory submission before the end of the year. The company will also look to double its 87-person team, including its recent hire of Jay Srinivasan, former vice president of automation and informatics at Abbott.
Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing
Funding Will Accelerate FDA Submission and Commercialization of Automated Benchtop Blood Testing System
TYH Ventures, Glen Tullman of 7WireVentures, and Wittington Ventures Led the Round, Joined by General Catalyst, GreatPoint Ventures, DNS Capital, and Wasson Enterprise
Prominent Industry Leaders Join Executive Team and Board of Directors
News provided by
Share this article
Share this article
SAN DIEGO, Feb. 24, 2021 /PRNewswire/ Truvian Sciences ( Truvian ) today announced the close of more than $105 million in an oversubscribed Series C financing round led by TYH Ventures, Glen Tullman of 7wireVentures, and Wittington Ventures. The funds will advance development of Truvian s automated benchtop blood testing system, paving the way to submit the device for U.S. Food and Drug Administration (FDA) clearance, and enabling the company to scale its team in preparation for broad commercializatio
Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.